Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Drugs and Therapy
Published in: Cardiovascular Drugs and Therapy 1/2001

01-01-2001

The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction

Authors: Bertram Pitt, Gordon Williams, Willem Remme, Felipe Martinez, Jose Lopez-Sendon, Faiez Zannad, James Neaton, Barbara Roniker, Steve Hurley, Dan Burns, Richard Bittman, Jay Kleiman

Published in: Cardiovascular Drugs and Therapy | Issue 1/2001

Login to get access
Metadata
Title
The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction
Authors
Bertram Pitt
Gordon Williams
Willem Remme
Felipe Martinez
Jose Lopez-Sendon
Faiez Zannad
James Neaton
Barbara Roniker
Steve Hurley
Dan Burns
Richard Bittman
Jay Kleiman
Publication date
01-01-2001
Publisher
Kluwer Academic Publishers
Published in
Cardiovascular Drugs and Therapy / Issue 1/2001
Print ISSN: 0920-3206
Electronic ISSN: 1573-7241
DOI
https://doi.org/10.1023/A:1011119003788

Other articles of this Issue 1/2001

Cardiovascular Drugs and Therapy 1/2001 Go to the issue

OriginalPaper

Adeno-Associated Virus-Mediated Transfer of Endothelial Nitric Oxide Synthase Gene Inhibits Protein Synthesis of Rat Ventricular Cardiomyocytes

Letter to the Editor

Effect of Angiotensin Converting Enzyme Inhibitor on Plasma von Willebrand Factor Level in Patients with Coronary Artery Disease

OriginalPaper

Disopyramide and Its Metabolite Enhance Insulin Release from Clonal Pancreatic β-Cells by Blocking KATP Channels

Editorial Board

A New Editorial Office

OriginalPaper

Late Coronary Artery Reperfusion has Additive Beneficial Effects on Infarct Expansion when Combined with Early Angiotensin Converting Enzyme Inhibitor Therapy Post Myocardial Infarction

OriginalPaper

Myocardial Lactate Release After Intracoronary Verapamil Application in Humans: Acute Effects of Intracoronary Verapamil on Systemic and Coronary Hemodynamics, Myocardial Metabolism, and Norepinephrine Levels

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits